(21406994), M. A., (14829313), M. A., (16561323), L. S., (21406997), M. S. E., (14777713), S. A., (14779351), R. Y. T., & (21407000), S. A. E. (2023). Polatuzumab Vedotin in a Patient with Refractory Burkitt Lymphoma, a Case Report.
Chicago Style (17th ed.) Citation(21406994), Meshaal Alanzi, Mohammad Abu-Tineh (14829313), Lajos Szabados (16561323), MZ Sharaf Eldean (21406997), Sali Alatasi (14777713), Ruba Y Taha (14779351), and Sarah A Elkourashy (21407000). Polatuzumab Vedotin in a Patient with Refractory Burkitt Lymphoma, a Case Report. 2023.
MLA (9th ed.) Citation(21406994), Meshaal Alanzi, et al. Polatuzumab Vedotin in a Patient with Refractory Burkitt Lymphoma, a Case Report. 2023.
Warning: These citations may not always be 100% accurate.